Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis

CONCLUSIONS: Pretreatment systemic inflammatory markers are associated with survival outcomes in patients with EC, with the HALP score being a prognostic factor for PFS and OS.PMID:38113633 | DOI:10.1016/j.ygyno.2023.12.007
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research